Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06250725 · ClinicalTrials.gov registry record · NA

Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners

A NA study of Dementia and Sleep Disturbance, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06250725 is a NA study of Dementia and Sleep Disturbance that is actively recruiting participants, run by Emory University. The registered enrollment target is 80 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06250725, a NA study of Dementia and Sleep Disturbance, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if a 6-week videoconference intervention to teach skills to improve sleep is practical, acceptable, and helpful to persons living with memory loss, cognitive impairment, and/or dementia and care partners, individually or together.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Insomnia

Study Locations (1)

Georgia

  • Emory Healthcare System - Atlanta

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-08-01
Est. Completion 2026-09
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT06250725

The ClinicalTrials.gov registry entry for NCT06250725 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy for Insomnia is the first listed.

NCT06250725 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06250725 about?

NCT06250725 is a clinical study titled "Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners". The purpose of this study is to determine if a 6-week videoconference intervention to teach skills to improve sleep is practical, acceptable, and helpful to persons living with memory loss, cognitive impairment, and/or dementia and care partners, individually or together.

What is the current status of trial NCT06250725?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-08-01. Estimated completion is 2026-09.

What conditions does trial NCT06250725 study?

This clinical trial studies the following conditions: Dementia, Sleep Disturbance.

What interventions are being tested in trial NCT06250725?

The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT06250725?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06250725 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.